KCNQ potassium channels: New targets for pulmonary vasodilator drugs?

Advances in Experimental Medicine and Biology

Volumn 661, Issue , 2010, Pages 405-417

  Gurney, Alison M ^a   Joshi, Shreena ^b   Manoury, Boris ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Flupirtine; K2P; KCNQ; Kv1.7; Membrane potential; Pulmonary arterial hypertension; Pulmonary artery; Retigabine

Indexed keywords

CALCIUM ION; DELAYED RECTIFIER POTASSIUM CHANNEL; FLUPIRTINE; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KV1.7; RETIGABINE; SHAB POTASSIUM CHANNEL; SHAKER POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; ISOPROTEIN; VASODILATOR AGENT;

ARTERY DIAMETER; ARTERY TONE; BLOOD PRESSURE; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CHANNEL GATING; CONFERENCE PAPER; DRUG MECHANISM; DRUG TARGETING; HUMAN; LUNG BLOOD FLOW; LUNG CIRCULATION; MEMBRANE STEADY POTENTIAL; NONHUMAN; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIDE EFFECT; SMOOTH MUSCLE FIBER; VASODILATATION; ANIMAL; CELL MEMBRANE POTENTIAL; CHEMISTRY; CLINICAL TRIAL; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; HYPERTENSION, PULMONARY; KCNQ POTASSIUM CHANNELS; MEMBRANE POTENTIALS; MYOCYTES, SMOOTH MUSCLE; PROTEIN ISOFORMS; PULMONARY ARTERY; VASODILATOR AGENTS;

EID: 77951250058     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-500-2_26     Document Type: Conference Paper

References (49)

1. Wang J, Juhaszova M, Rubin LJ, Yuan XJ (1997) Hypoxia inhibits gene expression of voltagegated K+ channel a-subunits in pulmonary artery smooth muscle cells. J Clin Invest 100:2347-2353 (Pubitemid 27500159)
2. Osipenko ON, Alexander D, MacLean MR, Gurney AM (1998) Influence of chronic hypoxia on the contributions of non-inactivating and delayed rectifier K currents to the resting potential and tone of rat pulmonary artery smooth muscle. Br J Pharmacol 124:1335-1337 (Pubitemid 28360552)
3. Remillard CV, Tigno DD, Platoshyn O et al (2007) Function of KV1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol 292:C1837-C1853 (Pubitemid 47080568)
4. Burg ED, Remillard CV, Yuan JX-J (2008) Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol 153:S99-S111 (Pubitemid 351341007)
5. Pozeg ZI, Michelakis ED McMurtry MS et al (2003) In vivo gene transfer of the O2-sensitive potassium channel KV1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation 107:2037-2044 (Pubitemid 36506080)
6. Wanstall JC (1996) The pulmonary vasodilator properties of potassium channel opening drugs. Gen Pharmacol 27:599-605 (Pubitemid 26233327)
7. Dalby-Brown W, Hansen HH, Korsgaard MP, Mirza N, Olesen SP (2006) KV7 channels: function, pharmacology and channel modulators. Curr Top Med Chem 6:999-1023 (Pubitemid 43796962)
8. Morecroft I, Murray A, Nilsen M, Gurney AM, MacLean MR (2009) The KV7 potassium channel activator flupirtine prevents pulmonary hypertension in two independent mouse models. Br J Pharmacol 157:1241-1249
9. Alexander SPH, Mathie A, Peters JA (2008) Guide to receptors and channels (GRAC). Br J Pharmacol 153:S130-S132
10. Moudgil R, Michelakis ED, Archer SL (2006) The role of K+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 13:615-632 (Pubitemid 44696118)
11. Archer SL, Souil E, Dinh-Xuan AT et al (1998) Molecular identification of the role of voltagegated K+ channels, KV1.5 and KV2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101:2319-2330 (Pubitemid 28270426)
12. Yuan XJ, Wang J, Juhaszova M, Golovina VA, Rubin LJ (1998) Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. Am J Physiol 274:L621-L635 (Pubitemid 28225347)
13. Patel AJ, Lazdunski M, Honoré E (1997) KV2.1/KV9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J 16:6615-6625 (Pubitemid 27503474)
14. Osipenko ON, Tate RJ, Gurney AM (2000) Potential role for KV3.1b channels as oxygen sensors. Circ Res 86:534-540 (Pubitemid 30165045)
15. Davies AR, Kozlowski RZ (2001) KV channel subunit expression in rat pulmonary arteries. Lung 179:147-161 (Pubitemid 34033111)
16. Coppock EA, Tamkun MM (2001) Differential expression of KV channel a- and b-subunits in the bovine pulmonary arterial circulation. Am J Physiol Lung Cell Mol Physiol 281:L1350-L1360
17. Platoshyn O, Remillard CV, Fantozzi I et al (2004) Diversity of voltage-dependent K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 287:L226-L238 (Pubitemid 38787670)
18. Iida H, Jo T, Iwasawa K et al (2005) Molecular and pharmacological characteristics of transient voltage-dependent K+ currents in cultured human pulmonary arterial smooth muscle cells. Br J Pharmacol 146:49-59 (Pubitemid 43086094)
19. Joshi S, Sedivy V, Hodyc D, Herget J, Gurney AM (2009) KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle. J Pharmacol Exp Ther 329:368-376
20. Joshi S, Balan P, Gurney AM (2006) Pulmonary vasoconstrictor action of KCNQ potassium channel blockers. Respir Res 7:31-41
21. Koh SD, Monaghan K, Sergeant GP et al (2001) TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase. An essential role in smooth muscle inhibitory neurotransmission. J Biol Chem 276:44338-44346
22. Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE (2003) Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 93:957-964 (Pubitemid 37433233)
23. Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH (2004) Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 142:192-202 (Pubitemid 38698208)
24. Clapp LH, Davey R, Gurney AM (1993) ATP-sensitive K+ channels mediate vasodilation produced by lemakalim in rabbit pulmonary artery. Am J Physiol 264:H1907-H1915 (Pubitemid 23205963)
25. Cui Y, Tran S, Tinker A, Clapp LH (2002) The molecular composition of KATP channels in human pulmonary artery smooth muscle cells and their modulation by growth. Am J Respir Cell Mol Biol 26:135-143 (Pubitemid 34029830)
26. Tennant BP, Cui Y, Tinker A, Clapp LH (2006) Functional expression of inward rectifier potassium channels in cultured human pulmonary smooth muscle cells: evidence for a major role of Kir2.4 subunits. J Membr Biol 213:19-29 (Pubitemid 46440139)
27. Casteels R, Kitamura K, Kuriyama H, Suzuki H (1977) Excitation- contraction coupling in the smooth muscle cells of the rabbit main pulmonary artery. J Physiol 271:63-79 (Pubitemid 8178788)
28. Suzuki H, Twarog BM (1982) Membrane properties of smooth muscle cells in pulmonary arteries of the rat. Am J Physiol 242:H900-H906 (Pubitemid 12040796)
29. Gurney AM (2004) Functional roles of ion channels in the regulation of membrane potential and pulmonary vascular tone. In: Yuan JX-J (ed) Ion channels in the pulmonary vasculature (lung biology in health and disease). Dekker, New York, pp 447-461
30. Clapp LH, Gurney AM (1991) Outward currents in rabbit pulmonary artery cells dissociated with a new technique. Exp Physiol 76:677-693
31. Gurney AM, Joshi S (2006) The role of twin pore domain and other K+ channels in hypoxic pulmonary vasoconstriction. Novartis Found Symp 272:218-228
32. Clapp LH, Gurney AM (1991) Modulation of calcium movements by nitroprusside in isolated vascular smooth muscle cells. Pflügers Arch 418:462-470
33. Yuan XJ, Wang J, Juhaszova M, Gaine SP, Rubin LJ (1998) Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 351:726-727 (Pubitemid 28105348)
34. Archer SL, Wu XC, Thébaud B et al (2004) Preferential expression and function of voltagegated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 95:308-318 (Pubitemid 39056292)
35. Coetzee WA, Amarillo Y, Chiu J et al (1999) Molecular diversity of K+ channels. Ann N Y Acad Sci 868:233-285
36. Osipenko ON, Alexander D, MacLean MR, Gurney AM (1998) Influence of chronic hypoxia on the contributions of non-inactivating and delayed rectifier K currents to the resting potential and tone of rat pulmonary artery smooth muscle. Br J Pharmacol 124:1335-1337 (Pubitemid 28360552)
37. Archer SL, London B, Hampl V et al (2001) Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel KV1.5. FASEB J 15:1801-1803
38. Gurney A, Manoury B (2009) Two-pore potassium channels in the cardiovascular system. Eur Biophys J 38:305-318
39. Gurney AM, Hunter E (2005) The use of small interfering RNA to elucidate the activity and function of ion channel genes in an intact tissue. J Pharmacol Toxicol Methods 51:253-262 (Pubitemid 40615605)
40. Olschewski A, Li Y, Tang B et al (2006) Impact of TASK-1 in human pulmonary artery smooth muscle cells. Circ Res 98:1072-1080
41. Gönczi M, Szentandrássy N, Johnson IT, Heagerty AM, Weston AH (2006) Investigation of the role of TASK-2 channels in rat pulmonary arteries; pharmacological and functional studies following RNA interference procedures. Br J Pharmacol 147:496-505 (Pubitemid 43355047)
42. Bieger D, Parai K, Ford CA, Tabrizchi R (2006) b-Adrenoceptor mediated responses in rat pulmonary artery: putative role of TASK-1 related K channels. Naunyn Schmiedebergs Arch Pharmacol 373:186-196 (Pubitemid 43829492)
43. Tang B, Li Y, Nagaraj C et al (2009) Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 41:467-483
44. Bryan RM Jr, Joseph BK, Lloyd E, Rusch NJ (2007) Starring TREK-1: the next generation of vascular K+ channels. Circ Res 101:119-121 (Pubitemid 47196578)
45. Evans AM, Osipenko ON, Gurney AM (1996) Properties of a novel K+ current that is active at resting potential in rabbit pulmonary artery smooth muscle cells. J Physiol 496:407-420 (Pubitemid 26370913)
46. McCartney CE, McClafferty H, Huibant JM, Rowan EG, Shipston MJ, Rowe IC (2005) A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltageand Ca-activated K (BK) channel a-subunits. Proc Natl Acad Sci U S A 102:17870-17876
47. Resnik E, Herron J, Fu R, Ivy DD, Cornfield DN (2006) Oxygen tension modulates the expression of pulmonary vascular BKCa channel a- and b-subunits. Am J Physiol Lung Cell Mol Physiol 290:L761-L768 (Pubitemid 43725082)
48. Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM (2007) Randomized, multicenter, doseranging trial of retigabine for partial-onset seizures. Neurology 68:1197-1204 (Pubitemid 46608467)
49. Li C, Ni J, Wang Z et al (2008) Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial. Curr Med Res Opin 24:3523-3530